BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 15, 2010
View Archived Issues
ATL-313 and dexamethasone have synergistic antitumor effect in models of multiple myeloma
Read More
Tasocitinib shows promising pharmacokinetics in ocular tissues
Read More
Vertex Pharmaceuticals patents new protein kinase C inhibitors
Read More
New ligands of nicotinic acetylcholine receptor alpha 7 disclosed by NeuroSearch
Read More
Treatment complete in phase II trial of fasitibant in osteoarthritis
Read More
Lilly suspends phase III trial of tasisulam in metastatic melanoma
Read More
Merck Frosst identifies potent 5-LO inhibitor MK-5286
Read More
CCX-721 has antitumor effects in murine model of multiple myeloma
Read More
Scientists identify new genetic link to risk of psoriasis
Read More
Angelica Therapeutics receives grant for anticancer candidate angeloxin
Read More
Orexo's new sublingual tablet formulation of buprenorphine/naloxone completes phase I trial
Read More
New PI3K-delta/gamma inhibitors discovered at Cellzome
Read More
Santen launches Diquas in Japan for dry eye syndrome
Read More
Bepotastine besilate nasal spray advances into phase II trial in allergic rhinitis
Read More
New inhibitors of fatty-acid amide hydrolase 1 claimed
Read More
Preliminary phase Ib/IIa data presented on ibudilast in opioid addiction
Read More
Phase II trial of EGEN-001 in advanced ovarian cancer opens enrollment
Read More
FDA approves Prezista/ritonavir q.d. for treatment-experienced adults with HIV and no DRV RAMs
Read More
Lexicon Pharma reports phase IIa data on LX-2931 in rheumatoid arthritis
Read More
New inhibitors claimed of mitochondrial cytochrome P450 11B1/2
Read More
Anaphore and Mitsubishi Tanabe Pharma to develop protein therapies for autoimmune disorders
Read More
PATH MVI, Merck & Co. and NYU Langone Medical Center to develop malaria vaccine
Read More
MHRA accepts BioMarin's application for phase III GALNS trial in MPS IVA
Read More
Neurokine completes trial plan for etanercept in Alzheimer's-type memory loss after CABG surgery
Read More
Novartis to take full ownership of Alcon
Read More